| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Richard M Lovering, Shama R Iyer, Benjamin Edwards, Kay E Davie. Alterations of neuromuscular junctions in Duchenne muscular dystrophy. Neuroscience letters. vol 737. 2021-04-30. PMID:32818587. |
the focus of this review is on duchenne muscular dystrophy (dmd), which is caused by the absence of the protein dystrophin and is characterized as a neuromuscular disease in which muscle weakness, increased susceptibility to muscle injury, and inadequate repair appear to underlie the pathology. |
2021-04-30 |
2023-08-13 |
human |
| Luca Bello, Grazia D'Angelo, Matteo Villa, Aurora Fusto, Sara Vianello, Beatrice Merlo, Daniele Sabbatini, Andrea Barp, Sandra Gandossini, Francesca Magri, Giacomo P Comi, Marina Pedemonte, Paola Tacchetti, Valentina Lanzillotta, Federica Trucco, Adele D'Amico, Enrico Bertini, Guja Astrea, Luisa Politano, Riccardo Masson, Giovanni Baranello, Emilio Albamonte, Elisa De Mattia, Fabrizio Rao, Valeria A Sansone, Stefano Previtali, Sonia Messina, Gian Luca Vita, Angela Berardinelli, Tiziana Mongini, Antonella Pini, Marika Pane, Eugenio Mercuri, Andrea Vianello, Claudio Bruno, Eric P Hoffman, Lauren Morgenroth, Heather Gordish-Dressman, Craig M McDonald, Elena Pegorar. Genetic modifiers of respiratory function in Duchenne muscular dystrophy. Annals of clinical and translational neurology. vol 7. issue 5. 2021-04-19. PMID:32343055. |
furthermore, we analyzed pft associations with different dmd mutation types, and with genetic variants in spp1, ltbp4, cd40, and actn3, known to modify skeletal muscle weakness in dmd. |
2021-04-19 |
2023-08-13 |
Not clear |
| Layana Marques, Guilherme Augusto de Freitas Fregonezi, Ilsa Priscila Santos, Ana Aline Marcelino, Jéssica Danielle Medeiros da Fonsêca, Mario Emílio Teixeira Dourado-Júnior, Andrea Aliverti, Antonio Sarmento, Vanessa Regiane Resquet. Effects of Positioning on Cough Peak Flow and Muscular Electromyographic Activation in Duchenne Muscular Dystrophy. Respiratory care. vol 65. issue 11. 2021-02-25. PMID:32546537. |
advanced stages of duchenne muscular dystrophy (dmd) result in muscle weakness and the inability to generate an effective cough. |
2021-02-25 |
2023-08-13 |
human |
| Gang Liu, Dingyuan Ma, Jiahuang Li, Chunyu Luo, Yun Sun, Jingjing Zhang, Ping Hu, Wenwei Tang, Zhengfeng X. A novel COQ8A missense variant associated with a mild form of primary coenzyme Q10 deficiency type 4. Clinical biochemistry. vol 84. 2021-01-27. PMID:32553579. |
the objective of this study was to investigate the genetic cause of muscle weakness in a proband who had a negative dmd gene test for becker muscular dystrophy. |
2021-01-27 |
2023-08-13 |
Not clear |
| Justin S Dhindsa, Angela L McCall, Laura M Strickland, Anna F Fusco, Amanda F Kahn, Mai K ElMalla. Motor axonopathies in a mouse model of Duchenne muscular dystrophy. Scientific reports. vol 10. issue 1. 2021-01-21. PMID:32488044. |
skeletal muscle weakness and eventual muscle degradation due to loss of dystrophin are well-documented pathological hallmarks of dmd. |
2021-01-21 |
2023-08-13 |
mouse |
| Emma Koenig, Bhajan Singh, Jamie Woo. Mechanical insufflation-exsufflation for an individual with Duchenne muscular dystrophy and a lower respiratory infection. Respirology case reports. vol 5. issue 2. 2021-01-09. PMID:27999675. |
duchenne muscular dystrophy (dmd) is an x-linked recessive myopathy associated with progressive muscle weakness and wasting, loss of ambulation, respiratory insufficiency, weak cough, repeated respiratory infections, and ultimately death from respiratory failure in early adulthood. |
2021-01-09 |
2023-08-13 |
Not clear |
| Karima Relizani, Graziella Griffith, Lucía Echevarría, Faouzi Zarrouki, Patricia Facchinetti, Cyrille Vaillend, Christian Leumann, Luis Garcia, Aurélie Goyenvall. Efficacy and Safety Profile of Tricyclo-DNA Antisense Oligonucleotides in Duchenne Muscular Dystrophy Mouse Model. Molecular therapy. Nucleic acids. vol 8. 2021-01-09. PMID:28918017. |
a novel class of aons made of tricyclo-dna (tcdna) is considered very promising for the treatment of duchenne muscular dystrophy (dmd), a neuromuscular disease typically caused by frameshifting deletions or nonsense mutations in the gene-encoding dystrophin and characterized by progressive muscle weakness, cardiomyopathy, and respiratory failure in addition to cognitive impairment. |
2021-01-09 |
2023-08-13 |
mouse |
| Claudia R Senesac, Alison M Barnard, Donovan J Lott, Kavya S Nair, Ann T Harrington, Rebecca J Willcocks, Kirsten L Zilke, William D Rooney, Glenn A Walter, Krista Vandenborn. Magnetic Resonance Imaging Studies in Duchenne Muscular Dystrophy: Linking Findings to the Physical Therapy Clinic. Physical therapy. vol 100. issue 11. 2020-12-24. PMID:32737968. |
duchenne muscular dystrophy (dmd) is a muscle degenerative disorder that manifests in early childhood and results in progressive muscle weakness. |
2020-12-24 |
2023-08-13 |
Not clear |
| Jingyun Guan, Xinnong Liu, Haiyan Zhang, Xiaomeng Yang, Yanyan Ma, Yue Li, Zhongtao Gai, Yi Li. Reprogramming of human Peripheral Blood Mononuclear Cell (PBMC) from a Chinese patient suffering Duchenne muscular dystrophy to iPSC line (SDQLCHi007-A) carrying deletion of 49-50 exons in the DMD gene. Stem cell research. vol 42. 2020-12-04. PMID:31812072. |
duchenne muscular dystrophy (dmd), an x-linked genetic disorder characterized by progressive muscle weakness and atrophies affecting skeletal and cardiac muscles, is caused by mutations in dystrophin (dmd) gene that spans 79 exons. |
2020-12-04 |
2023-08-13 |
human |
| Lee-Jae Guo, Jonathan H Soslow, Amanda K Bettis, Peter P Nghiem, Kevin J Cummings, Mark W Lenox, Matthew W Miller, Joe N Kornegay, Christopher F Spurne. Natural History of Cardiomyopathy in Adult Dogs With Golden Retriever Muscular Dystrophy. Journal of the American Heart Association. vol 8. issue 16. 2020-11-10. PMID:31411085. |
background duchenne muscular dystrophy (dmd) is an x-linked disease that causes progressive muscle weakness. |
2020-11-10 |
2023-08-13 |
Not clear |
| Ines Vandekerckhove, Nathalie De Beukelaer, Marleen Van den Hauwe, Benjamin R Shuman, Katherine M Steele, Anja Van Campenhout, Nathalie Goemans, Kaat Desloovere, Marije Goudriaa. Muscle weakness has a limited effect on motor control of gait in Duchenne muscular dystrophy. PloS one. vol 15. issue 9. 2020-10-26. PMID:32877421. |
our aim was to determine if synergy weights and activations are altered in duchenne muscular dystrophy (dmd) and if these alterations could be linked to muscle weakness. |
2020-10-26 |
2023-08-13 |
Not clear |
| X Zikou, G Papathanakos, E Dounousi, G Nakos, V Kouloura. Hypokalemia-induced cardiac arrest in a Duchenne muscular dystrophy patient. Hippokratia. vol 20. issue 2. 2020-10-01. PMID:28416915. |
duchenne muscular dystrophy (dmd) is a progressive myopathic disorder, inherited as x-linked recessive traits, in which muscle weakness is the primary symptom. |
2020-10-01 |
2023-08-13 |
Not clear |
| Yuko Miyagoe-Suzuki, Takashi Nishiyama, Miho Nakamura, Asako Narita, Fusako Takemura, Satoru Masuda, Narihiro Minami, Kumiko Murayama, Hirofumi Komaki, Yu-Ichi Goto, Shin'ichi Taked. Induction of Pluripotent Stem Cells from a Manifesting Carrier of Duchenne Muscular Dystrophy and Characterization of Their X-Inactivation Status. Stem cells international. vol 2017. 2020-10-01. PMID:28491099. |
three to eight percent of female carriers of duchenne muscular dystrophy (dmd) develop dystrophic symptoms ranging from mild muscle weakness to a rapidly progressive dmd-like muscular dystrophy due to skewed inactivation of x chromosomes during early development. |
2020-10-01 |
2023-08-13 |
human |
| David P Burns, Izza Ali, Clement Rieux, James Healy, Greg Jasionek, Ken D O'Hallora. Tempol Supplementation Restores Diaphragm Force and Metabolic Enzyme Activities in mdx Mice. Antioxidants (Basel, Switzerland). vol 6. issue 4. 2020-10-01. PMID:29210997. |
duchenne muscular dystrophy (dmd) is characterized by striated muscle weakness, cardiomyopathy, and respiratory failure. |
2020-10-01 |
2023-08-13 |
mouse |
| Marije Goudriaan, Benjamin R Shuman, Katherine M Steele, Marleen Van den Hauwe, Nathalie Goemans, Guy Molenaers, Kaat Desloover. Non-neural Muscle Weakness Has Limited Influence on Complexity of Motor Control during Gait. Frontiers in human neuroscience. vol 12. 2020-10-01. PMID:29445330. |
cerebral palsy (cp) and duchenne muscular dystrophy (dmd) are neuromuscular disorders characterized by muscle weakness. |
2020-10-01 |
2023-08-13 |
Not clear |
| Mathula Thangarajh, Christopher F Spurney, Heather Gordish-Dressman, Paula R Clemens, Eric P Hoffman, Craig M McDonald, Erik K Henricso. Neurodevelopmental Needs in Young Boys with Duchenne Muscular Dystrophy (DMD): Observations from the Cooperative International Neuromuscular Research Group (CINRG) DMD Natural History Study (DNHS). PLoS currents. vol 10. 2020-10-01. PMID:30443431. |
duchenne muscular dystrophy (dmd) is the most common x-linked neuromuscular condition manifested by progressive skeletal muscle weakness, cardiopulmonary involvement and cognitive deficits. |
2020-10-01 |
2023-08-13 |
human |
| Yuko Shimizu-Motohashi, Hirofumi Komaki, Norio Motohashi, Shin'ichi Takeda, Toshifumi Yokota, Yoshitsugu Aok. Restoring Dystrophin Expression in Duchenne Muscular Dystrophy: Current Status of Therapeutic Approaches. Journal of personalized medicine. vol 9. issue 1. 2020-10-01. PMID:30621068. |
duchenne muscular dystrophy (dmd), a rare genetic disorder characterized by progressive muscle weakness, is caused by the absence or a decreased amount of the muscle cytoskeletal protein dystrophin. |
2020-10-01 |
2023-08-13 |
Not clear |
| Hathaichanok Tamiyakul, Elisabeth Kemter, Miwako Kösters, Stefanie Ebner, Andreas Blutke, Nikolai Klymiuk, Florian Flenkenthaler, Eckhard Wolf, Georg J Arnold, Thomas Fröhlic. Progressive Proteome Changes in the Myocardium of a Pig Model for Duchenne Muscular Dystrophy. iScience. vol 23. issue 9. 2020-10-01. PMID:32927262. |
duchenne muscular dystrophy (dmd), caused by mutations in the dystrophin gene, is characterized by progressive muscle weakness. |
2020-10-01 |
2023-08-13 |
human |
| Shabana Z Shafy, Mohammed Hakim, Mauricio Arce Villalobos, Gregory D Pearson, Giorgio Veneziano, Joseph D Tobia. Caudal epidural block instead of general anesthesia in an adult with Duchenne muscular dystrophy. Local and regional anesthesia. vol 11. 2020-09-30. PMID:30410390. |
duchenne muscular dystrophy (dmd), first described in 1834, is an x-linked dystrophinopathy, leading to early onset skeletal muscle weakness. |
2020-09-30 |
2023-08-13 |
Not clear |
| Rupam Sinha, Soumyabrata Sarkar, Tanya Khaitan, Soumyajit Dutt. Duchenne muscular dystrophy: Case report and review. Journal of family medicine and primary care. vol 6. issue 3. 2020-09-29. PMID:29417026. |
duchenne muscular dystrophy (dmd) is the most common x-linked disorder muscular dystrophy in children, presenting in early childhood and characterized by proximal muscle weakness and calf hypertrophy in affected boys. |
2020-09-29 |
2023-08-13 |
Not clear |